✦ LIBER ✦

Cutaneous toxicities of antiretroviral therapy for HIV: Part I. Lipodystrophy syndrome, nucleoside reverse transcriptase inhibitors, and protease inhibitors

✍ Scribed by Camille E. Introcaso; Janet M. Hines; Carrie L. Kovarik

Book ID: 116586745
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 660 KB
Volume: 63
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2010.01.061

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cutaneous toxicities of antiretroviral t

Cutaneous toxicities of antiretroviral therapy for HIV: Part I. Lipodystrophy syndrome, nucleoside reverse transcriptase inhibitors, and protease inhibitors

✍ Camille E. Introcaso; Janet M. Hines; Carrie L. Kovarik 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 660 KB

Antiretroviral medications for the treatment of HIV are common drugs with diverse and frequent skin manifestations. Multiple new cutaneous effects have been recognized in the past decade. Dermatologists play an important role in accurately diagnosing and managing the cutaneous toxicities of these me

Cutaneous toxicities of antiretroviral t

Cutaneous toxicities of antiretroviral therapy for HIV: Part II. Nonnucleoside reverse transcriptase inhibitors, entry and fusion inhibitors, integrase inhibitors, and immune reconstitution syndrome

✍ Camille E. Introcaso; Janet M. Hines; Carrie L. Kovarik 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 349 KB

Cutaneous toxicities of antiretroviral t

Cutaneous toxicities of antiretroviral therapy for HIV: Part II. Nonnucleoside reverse transcriptase inhibitors, entry and fusion inhibitors, integrase inhibitors, and immune reconstitution syndrome

✍ Camille E. Introcaso; Janet M. Hines; Carrie L. Kovarik 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 349 KB

Cutaneous manifestations of antiretroviral medications for HIV are common and potentially dangerous conditions encountered by dermatologists. Part II of this two-part series on the cutaneous effects of antiretroviral medications for HIV will discuss the four most recent classes of medications that h

Mitochondrial toxicity induced by nucleo

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

✍ Kees Brinkman; Jan A Smeitink; Johannes A Romijn; Peter Reiss 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 85 KB

Development of a pharmacodynamic model f

Development of a pharmacodynamic model for HIV treatment with nucleoside reverse transcriptase and protease inhibitors

✍ Selwyn J. Hurwitz; Raymond F. Schinazi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Design, synthesis and biological evaluat

Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I

✍ Tao Jiang; Kelli L. Kuhen; Karen Wolff; Hong Yin; Kimberly Bieza; Jeremy Caldwel 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 149 KB